Stay updated with breaking news from Caleres Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Caleres (NYSE:CAL – Get Rating) issued an update on its second quarter 2023 earnings guidance on Sunday morning. The company provided EPS guidance of $0.87-$0.92 for the period, compared to the consensus EPS estimate of $1.18. The company issued revenue guidance of $701.41 million-$708.80 million, compared to the consensus revenue estimate of $745.46 million. Caleres […]
Caleres (NYSE:CAL – Get Rating) issued an update on its FY 2023 earnings guidance on Sunday morning. The company provided EPS guidance of $4.10-$4.30 for the period, compared to the consensus EPS estimate of $4.57. The company issued revenue guidance of $2.82 billion-$2.88 billion, compared to the consensus revenue estimate of $2.98 billion. Caleres also […]
Caleres (NYSE:CAL – Get Rating) issued an update on its FY 2023 earnings guidance on Sunday morning. The company provided earnings per share (EPS) guidance of $4.10-$4.30 for the period, compared to the consensus estimate of $4.57. The company issued revenue guidance of $2.82 billion-$2.88 billion, compared to the consensus revenue estimate of $2.98 billion. […]
The newest vaccine, from Pfizer for a deadly respiratory virus known by the acronym RSV, was approved in the U.S. on Wednesday. Its green light follows clearance of the first RSV shot from GSK earlier this month and a pneumonia shot from Merck & Co... | 06:12am
Delivers $0.97 in earnings per share, the upper end of previous guidance Generates record quarterly operating earnings and operating margin in the Brand Portfolio segment Reiterates full year... | June 1, 2023